Role of spot urinary sodium in outpatients with heart failure

Miguel Lorenzo1, Rafael de la Espriella1, Gema Miñana2

  • 1Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.

Insights

Lower urinary sodium (UNa+) levels in chronic heart failure (HF) outpatients indicate a higher risk of worsening HF events. This finding supports UNa+ monitoring for better HF management.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Medicine

Background:

  • Spot urinary sodium (UNa+) monitoring is valuable for acute heart failure (AHF) diuretic response.
  • Evidence for UNa+ in chronic heart failure (HF) outpatients is limited.
  • Understanding UNa+ role in chronic HF is crucial for patient management.

Purpose of the Study:

  • To investigate the association between spot UNa+ levels and risks of mortality and worsening heart failure (WHF) in chronic HF outpatients.
  • To evaluate UNa+ as a predictor of adverse events in a real-world chronic HF cohort.

Main Methods:

  • An ambispective observational study included 1145 chronic HF outpatients.
  • Spot UNa+ was measured 1-5 days before clinic visits.
  • Multivariate Cox and negative binomial regressions assessed associations between UNa+ and mortality/WHF events.

Main Results:

  • The median UNa+ was 72 mmol/L; 25.6% experienced mortality and 20.3% had WHF events over ~2.6 years.
  • Lower baseline UNa+ showed a significant inverse linear association with total WHF events (IRR 1.07) and AHF-hospitalizations (IRR 1.08).
  • A borderline association was observed between lower UNa+ and all-cause mortality (HR 1.04).

Conclusions:

  • Lower spot urinary sodium levels are linked to increased risk of recurrent worsening heart failure events in chronic HF outpatients.
  • Spot UNa+ may serve as a useful biomarker for risk stratification in chronic HF management.
  • Further research can explore therapeutic implications of UNa+ monitoring in chronic HF.
Abstract

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
356
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
647
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
469
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
495
Regulation of Water Output01:26

Regulation of Water Output

The human body predominantly expels water through the urinary system. On average, an individual generates around 1.5 liters of urine each day. This amount can fluctuate based on how well a person is hydrated, but a critical minimum quantity of urine must be produced to ensure the body's proper functioning. Daily, the kidneys remove 600 to 1200 milliosmoles of dissolved substances, effectively excreting excess minerals and water-soluble toxins such as creatinine, urea, and uric acid from the...
282